99 related articles for article (PubMed ID: 8030161)
1. Fungal prophylaxis with AmBisome in liver and bone marrow transplant recipients: results of two randomized double-blind studies.
Tollemar J; Höckerstedt K; Ericzon BG; Sundberg B; Ringdén O
Transplant Proc; 1994 Jun; 26(3):1833. PubMed ID: 8030161
[No Abstract] [Full Text] [Related]
2. Randomized double-blind study of liposomal amphotericin B (Ambisome) prophylaxis of invasive fungal infections in bone marrow transplant recipients.
Tollemar J; Ringdén O; Andersson S; Sundberg B; Ljungman P; Tydén G
Bone Marrow Transplant; 1993 Dec; 12(6):577-82. PubMed ID: 8136741
[TBL] [Abstract][Full Text] [Related]
3. Prophylaxis with liposomal amphotericin B (AmBisome) prevents fungal infections in liver transplant recipients: long-term results of a randomized, placebo-controlled trial.
Tollemar J; Höckerstedt K; Ericzon BG; Jalanko H; Ringdén O
Transplant Proc; 1995 Feb; 27(1):1195-8. PubMed ID: 7878847
[No Abstract] [Full Text] [Related]
4. Liposomal amphotericin (AmBisome) in the prophylaxis of fungal infections in neutropenic patients: a randomised, double-blind, placebo-controlled study.
Kelsey SM; Goldman JM; McCann S; Newland AC; Scarffe JH; Oppenheim BA; Mufti GJ
Bone Marrow Transplant; 1999 Jan; 23(2):163-8. PubMed ID: 10197802
[TBL] [Abstract][Full Text] [Related]
5. Low-dose amphotericin for prevention of serious fungal infection following liver transplantation.
Shah T; Lai WK; Gow P; Leeming J; Mutimer D
Transpl Infect Dis; 2005; 7(3-4):126-32. PubMed ID: 16390401
[TBL] [Abstract][Full Text] [Related]
6. Prophylactic use of liposomal amphotericin B (AmBisome) against fungal infections: a randomized trial in bone marrow transplant recipients.
Tollemar J; Ringdén O; Andersson S; Sundberg B; Ljungman P; Sparrelid E; Tydén G
Transplant Proc; 1993 Feb; 25(1 Pt 2):1495-7. PubMed ID: 8442163
[No Abstract] [Full Text] [Related]
7. Safety of liposomal amphotericin B (AmBisome) in 187 transplant recipients treated with cyclosporin.
Ringdén O; Andström E; Remberger M; Svahn BM; Tollemar J
Bone Marrow Transplant; 1994; 14 Suppl 5():S10-4. PubMed ID: 7703925
[TBL] [Abstract][Full Text] [Related]
8. Prophylaxis and therapy using liposomal amphotericin B (AmBisome) for invasive fungal infections in children undergoing organ or allogeneic bone-marrow transplantation.
Ringdén O; Andström EE; Remberger M; Dahllöf G; Svahn BM; Tollemar J
Pediatr Transplant; 1997 Nov; 1(2):124-9. PubMed ID: 10084772
[TBL] [Abstract][Full Text] [Related]
9. High cure rate of invasive fungal infections in immunocompromised children using ambisome.
Ringdén O; Tollemar J; Dahllöf G; Tydén G
Transplant Proc; 1994 Feb; 26(1):175-7. PubMed ID: 8108927
[No Abstract] [Full Text] [Related]
10. Compassionate use protocol initiated for AmBisome.
J Int Assoc Physicians AIDS Care; 1996 Apr; 2(4):60. PubMed ID: 11363524
[TBL] [Abstract][Full Text] [Related]
11. [Usefulness of liposomal amphotericin B for the prophylaxis of fungal infection in solid organ transplant recipients].
López-Medrano F; Díaz-Pedroche C; Lumbreras C; Aguado JM
Rev Esp Quimioter; 2005 Mar; 18(1):14-20. PubMed ID: 15915227
[TBL] [Abstract][Full Text] [Related]
12. Prospective interventional study to evaluate the efficacy and safety of liposomal amphotericin B as prophylaxis of fungal infections in high-risk liver transplant recipients.
Castroagudín JF; Pontón C; Bustamante M; Otero E; Martínez J; Tomé S; Conde R; Segade FR; Delgado M; Brage A; Galbán C; Varo E
Transplant Proc; 2005 Nov; 37(9):3965-7. PubMed ID: 16386598
[TBL] [Abstract][Full Text] [Related]
13. Safety and efficacy of liposomal amphotericin B in allogeneic bone marrow transplant recipients.
Andström EE; Ringdén O; Remberger M; Svahn BM; Tollemar J
Mycoses; 1996; 39(5-6):185-93. PubMed ID: 8909028
[TBL] [Abstract][Full Text] [Related]
14. Targeted prophylaxis with amphotericin B lipid complex in liver transplantation.
Singhal S; Ellis RW; Jones SG; Miller SJ; Fisher NC; Hastings JG; Mutimer DJ
Liver Transpl; 2000 Sep; 6(5):588-95. PubMed ID: 10980058
[TBL] [Abstract][Full Text] [Related]
15. Liposomal amphotericin B as antifungal prophylaxis in bone marrow transplant patients.
Falagas ME; Vardakas KZ
Am J Hematol; 2006 Apr; 81(4):299-300. PubMed ID: 16550510
[No Abstract] [Full Text] [Related]
16. Use of liposomal amphotericin B in bone marrow transplant.
Sastry PS; Parikh PM; Kulkarni PS; Bhagwat R; Gadade H
J Postgrad Med; 2005; 51 Suppl 1():S49-52. PubMed ID: 16519256
[TBL] [Abstract][Full Text] [Related]
17. A retrospective clinical comparison between antifungal treatment with liposomal amphotericin B (AmBisome) and conventional amphotericin B in transplant recipients.
Tollemar J; Andersson S; Ringdén O; Tydén G
Mycoses; 1992; 35(9-10):215-20. PubMed ID: 1291871
[TBL] [Abstract][Full Text] [Related]
18. Effect of prophylaxis on fungal infection and costs for high-risk liver transplant recipients.
Reed A; Herndon JB; Ersoz N; Fujikawa T; Schain D; Lipori P; Hemming A; Li Q; Shenkman E; Vogel B
Liver Transpl; 2007 Dec; 13(12):1743-50. PubMed ID: 18044769
[TBL] [Abstract][Full Text] [Related]
19. Reply: Effect of prophylaxis on fungal infection and costs for high-risk liver transplant recipients.
Huprikar S
Liver Transpl; 2008 May; 14(5):709. PubMed ID: 18433053
[No Abstract] [Full Text] [Related]
20. Controlled trials of amphotericin B lipid complex.
Boyle JA
Clin Infect Dis; 2000 Oct; 31(4):1117-8. PubMed ID: 11049803
[No Abstract] [Full Text] [Related]
[Next] [New Search]
